Atlas Trials

Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen

Clinical trial NCT02623556 · COMPLETED

Trial details

NCT number
NCT02623556
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tuberculosis
Start date
2015-12-01
Primary completion
2018-03-01
Enrollment
1090

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.